Skip to main content
Top

Trials

Issue 1/2002

Content (10 Articles)

Open Access Research

Weight-modification trials in older adults: what should the outcome measure be?

Paula Diehr, Anne B Newman, Sharon A Jackson, Lewis Kuller, Neil Powe

Open Access Review

Clinical significance of cardiovascular dysmetabolic syndrome

Prakash C Deedwania

Open Access Research

Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors

Chiara Chiabrando, Fausto Avanzini, Claudia Rivalta, Fabio Colombo, Roberto Fanelli, Gaetana Palumbo, Maria Carla Roncaglioni

Open Access Commentary

Pooling, meta-analysis, and the evaluation of drug safety

Michel Lièvre, Michel Cucherat, Alain Leizorovicz

Open Access Research

A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics

Ian Ford, Gerard Jan Blauw, Michael B Murphy, James Shepherd, Stuart M Cobbe, Edward LEM Bollen, Brendan M Buckley, J Wouter Jukema, Michael Hyland, Allan Gaw, A Margot Lagaay, Ivan J Perry, Peter Macfarlane, John Norrie, A Edo Meinders, Brian J Sweeney, Chris J Packard, Rudi GJ Westendorp, Cillian Twomey, David J Stott

Open Access Research

A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data

Scott A Lear, Andrew Ignaszewski, Wolfgang Linden, Anka Brozic, Marla Kiess, John J Spinelli, P Haydn Pritchard, Jiri J Frohlich

Open Access Research

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

Linda B Piller, Barry R Davis, Jeffrey A Cutler, William C Cushman, Jackson T Wright Jr, Jeff D Williamson, Frans HH Leenen, Paula T Einhorn, Otelio S Randall, John S Golden, L Julian Haywood